[go: up one dir, main page]

NO20011402L - Tricykliske <delta>3-piperidiner som farmasöytiske midler - Google Patents

Tricykliske <delta>3-piperidiner som farmasöytiske midler

Info

Publication number
NO20011402L
NO20011402L NO20011402A NO20011402A NO20011402L NO 20011402 L NO20011402 L NO 20011402L NO 20011402 A NO20011402 A NO 20011402A NO 20011402 A NO20011402 A NO 20011402A NO 20011402 L NO20011402 L NO 20011402L
Authority
NO
Norway
Prior art keywords
parta
piperidines
tricyclic
pharmaceutical agents
pharmaceutical
Prior art date
Application number
NO20011402A
Other languages
English (en)
Other versions
NO20011402D0 (no
Inventor
Ludo Edmond Josephine Kennis
Josephus Carolus Mertens
Mirielle Braeken
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO20011402L publication Critical patent/NO20011402L/no
Publication of NO20011402D0 publication Critical patent/NO20011402D0/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • C07D491/044Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Ophthalmology & Optometry (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Emergency Medicine (AREA)
  • Psychology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO20011402A 1998-10-06 2001-03-20 Tricykliske <delta>3-piperidiner som farmasøytiske midler NO20011402D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98203371 1998-10-06
PCT/EP1999/007420 WO2000020423A1 (en) 1998-10-06 1999-10-01 Tricyclic δ3-piperidines as pharmaceuticals

Publications (2)

Publication Number Publication Date
NO20011402L true NO20011402L (no) 2001-03-20
NO20011402D0 NO20011402D0 (no) 2001-03-20

Family

ID=8234192

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20011402A NO20011402D0 (no) 1998-10-06 2001-03-20 Tricykliske <delta>3-piperidiner som farmasøytiske midler

Country Status (27)

Country Link
US (1) US6352999B1 (no)
EP (1) EP1119570B1 (no)
JP (1) JP4590102B2 (no)
KR (1) KR20010071844A (no)
CN (1) CN1131868C (no)
AR (1) AR023679A1 (no)
AT (1) ATE269337T1 (no)
AU (1) AU759199B2 (no)
BG (1) BG64871B1 (no)
BR (1) BR9913108A (no)
CA (1) CA2346082C (no)
CZ (1) CZ20011105A3 (no)
DE (1) DE69918148T2 (no)
EE (1) EE04680B1 (no)
ES (1) ES2222735T3 (no)
HU (1) HUP0103749A3 (no)
ID (1) ID28451A (no)
IL (2) IL142444A0 (no)
NO (1) NO20011402D0 (no)
NZ (1) NZ510116A (no)
PL (1) PL347179A1 (no)
RU (1) RU2226194C2 (no)
SK (1) SK285386B6 (no)
TR (1) TR200100953T2 (no)
TW (1) TWI244485B (no)
UA (1) UA70961C2 (no)
WO (1) WO2000020423A1 (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA69420C2 (uk) * 1998-10-06 2004-09-15 Янссен Фармацевтика Н.В. ТРИЦИКЛІЧНІ <font face="Symbol">D3</font>-ПІПЕРИДИНИ ЯК <font face="Symbol">a<sub></font>2</sub>-АНТАГОНІСТИ
JP2005522407A (ja) * 2001-07-05 2005-07-28 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー 治療用化合物
WO2003082825A1 (en) * 2002-04-03 2003-10-09 Orion Corporation Use of an alfa2-adrenoreceptor antagonist for cns-related diseases
MXPA06011777A (es) 2004-04-12 2007-01-16 Taisho Pharma Co Ltd Compuesto de amina ciclico.
BRPI0608353A2 (pt) 2005-02-17 2009-12-01 Wyeth Corp derivados de indol, benzotiofeno, benzofurano e indeno cicloalquilfundidos
DE102005038947A1 (de) * 2005-05-18 2006-11-30 Grünenthal GmbH Substituierte Benzo[d]isoxazol-3-yl-amin-Verbindungen und deren Verwendung in Arzneimitteln
EP3026049B1 (en) 2013-07-25 2021-09-22 Dong-A ST Co., Ltd. Method for preparing benzamide derivative, novel intermediate used in preparation of benzamide, and method for preparing novel intermediate
CN103755715B (zh) * 2013-12-26 2015-12-09 武汉理工大学 苯并呋喃并[2,3-c]吡啶化合物及其合成方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU926914A1 (ru) * 1980-05-26 1992-04-23 Научно-исследовательский институт фармакологии АМН СССР Производные 1,2,3,4-тетрагидробензофуро[3,2-с]-пиридина или хлоргидрат, обладающие р дом свойств анальгетиков и антагонистов морфина
DE3522959A1 (de) 1985-06-27 1987-01-08 Merck Patent Gmbh Indolderivate
US4673680A (en) * 1985-09-18 1987-06-16 Pendleton Robert G α2 -adrenergic receptor antagonists as modifiers of gastrointestinal motility
JPH0256485A (ja) * 1988-04-27 1990-02-26 Glaxo Group Ltd ラクタム誘導体
US4971974A (en) * 1988-06-16 1990-11-20 Neurex Corporation Benzothiophenes as appetite suppressants
US5100891A (en) * 1991-01-18 1992-03-31 Hoechst-Roussel Pharmaceuticals Inc. Substituted 1,2,3,4-tetrahydrocyclopent[b]indoles, 1,2,3,3a,4,8a-hexahydrocyclopent[B]indoles and related compounds
ES2168682T3 (es) * 1996-12-06 2002-06-16 Abbott Lab Compuestos alfa-1 adrenergicos a base de benzopiranopirrol y de benzopiranopiridina.
UA52681C2 (uk) 1997-04-08 2003-01-15 Янссен Фармацевтика Н.В. Похідні 1,2,3,4-тетрагідро-бензофуро[3,2,-c]піридину, спосіб їх одержання та фармацевтична композиція на їх основі
UA69420C2 (uk) * 1998-10-06 2004-09-15 Янссен Фармацевтика Н.В. ТРИЦИКЛІЧНІ <font face="Symbol">D3</font>-ПІПЕРИДИНИ ЯК <font face="Symbol">a<sub></font>2</sub>-АНТАГОНІСТИ

Also Published As

Publication number Publication date
PL347179A1 (en) 2002-03-25
AU759199B2 (en) 2003-04-10
EP1119570B1 (en) 2004-06-16
CA2346082A1 (en) 2000-04-13
TR200100953T2 (tr) 2001-09-21
DE69918148D1 (de) 2004-07-22
BG105334A (bg) 2001-11-30
IL142444A0 (en) 2002-03-10
HUP0103749A3 (en) 2003-03-28
SK4332001A3 (en) 2001-12-03
ID28451A (id) 2001-05-24
CZ20011105A3 (cs) 2001-12-12
US6352999B1 (en) 2002-03-05
WO2000020423A1 (en) 2000-04-13
CN1131868C (zh) 2003-12-24
KR20010071844A (ko) 2001-07-31
DE69918148T2 (de) 2005-07-28
HUP0103749A2 (hu) 2002-02-28
NZ510116A (en) 2002-10-25
ES2222735T3 (es) 2005-02-01
CN1321158A (zh) 2001-11-07
SK285386B6 (sk) 2006-12-07
NO20011402D0 (no) 2001-03-20
RU2226194C2 (ru) 2004-03-27
AU6334299A (en) 2000-04-26
BR9913108A (pt) 2001-05-08
EE200100210A (et) 2002-06-17
CA2346082C (en) 2010-02-16
EE04680B1 (et) 2006-08-15
HK1038009A1 (en) 2002-03-01
JP2002526547A (ja) 2002-08-20
AR023679A1 (es) 2002-09-04
EP1119570A1 (en) 2001-08-01
TWI244485B (en) 2005-12-01
UA70961C2 (uk) 2004-11-15
BG64871B1 (bg) 2006-07-31
ATE269337T1 (de) 2004-07-15
IL142444A (en) 2008-03-20
JP4590102B2 (ja) 2010-12-01

Similar Documents

Publication Publication Date Title
NO20014412D0 (no) Forbindelser nyttige som anti-inflammatoriske midler
NO20013671L (no) Substituerte bisycliske derivater nyttige som anticancer midler
DE60013221D1 (de) Fotopolymerisierbare Zusammensetzung
DK1212327T3 (da) Pyrazolopyrimidiner som terapeutiske midler
DE50007817D1 (de) Mikrospiegel
EE200100525A (et) Adamantaani derivaadid
NO20015477L (no) 4,5,6,7-tetrahydroindazolderivater som antitumormidler
IS2246B (is) Adamantanafleiður
EE200200295A (et) Adamantaani derivaadid
NO20002217D0 (no) Cyclopentan-heptansyre, 2-heteroarylalkenylderivater som terapeutiske midler
ATE293104T1 (de) Thiazolylamid-derivate
DK0975623T3 (da) Indazolamidforbindelser som sertoninerge midler
PT1237857E (pt) Novos derivados fenalquiloxi-fenilo
DK1086097T3 (da) Sulfonylbenzenforbindelser som anti-inflammatoriske/analgetiske midler
NO991560D0 (no) PDE IV som inhiberer 2-cyanoiminoimidazol-derivater
DE50015811D1 (de) Retardersystem
DE60016836D1 (de) Resistzusammensetzung
ATE273272T1 (de) Mevinolinderivate
NO20014926L (no) Farmasöytiske forbindelser
ATE374747T1 (de) Monofluoralkylderivate
ATE254598T1 (de) 4-hydroxybiphenylhydrazid-derivate
ATE293592T1 (de) Resorcinderivate
DE50015381D1 (de) Retardersystem
NO20011402L (no) Tricykliske &lt;delta&gt;3-piperidiner som farmasöytiske midler
NO20011270D0 (no) Tricykliske &lt;delta&gt;3-piperidiner som &lt;alfa&gt;2-antagonister

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application